Table 3.
Treatment | 1st line females | 2nd line females | 3rd line females |
---|---|---|---|
No. fertile females (X ± SE) | |||
Fungus-free (control) | 7.5 ± 0.6a | 7.5 ± 0.6a | 6.0 ± 0.9a |
M. anisopliae | 3.4 ± 0.5b | 3.5 ± 0.9b | 6.0 ± 1.1a |
t | 6.92 | 5.90 | N/A |
P | 0.001 | 0.005 | N/A |
No. pupae/female (X ± SE) per female produced between 1 and 35 days after infection 1 | |||
Fungus-free (control) | 2.3 ± 0.2a | 2.5 ± 0.2a | 2.0 ± 0.1a |
M. anisopliae | 1.2 ± 0.1b | 1.4 ± 0.2b | 1.4 ± 0.3a |
t | 2.82 | 3.0 | 1.32 |
P | 0.030 | 0.025 | 0.245 |
No. pupae (X ± SE) 2 | |||
Fungus-free (control) | 4.0 ± 0.5a | 3.5 ± 0.5a | 3.5 ± 0.6a |
M. anisopliae | 1.4 ± 0.3b | 2.5 ± 0.9a | 2.1 ± 0.4b |
t | 4.2 | 1.41 | 4.37 |
P | 0.013 | 0.227 | 0.011 |
Four replicates of 10 flies each. Female flies mated with Metarhizium anisopliae-treated and fungus-free male ‘donor’
1Number of pupae/fly produced by fungus-treated flies that survived up to 35 days post-infection, and free-fungus flies for the same period
2Number of pupae produced per female over a period of 60 days post-infection. Means within-column followed by the same letter are not significantly different by t test (P > 0.05)